SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Terrence Von Holidae who wrote (616)4/8/1997 1:30:00 PM
From: Art Baer   of 1172
 
<Chemtrak is simply complying with accepted accounting practices in this instance of restatement to earnings>

One thing I have noticed over the past few weeks is that other companies who have had convertible debts that could be converted at a discount to the market also restated their earnings. One is Pinnalce Micro (PNCL) I think that the SEC must have contacted a batch of companies. It really does not matter because CMTR still has same amount of cash and I think that the effects reverse themselves once the debts are converted.

Art
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext